Home

GREGORY STEA

CIK 1456336 · SVP, Commercial Operations · last filed 2018-06-07

GREGORY STEA is a SVP, Commercial Operations who has filed 52 SEC Form 4 insider transactions across 3 companies since 2009. The most recent filing, for AKAO, was dated Jun 7, 2018. Across all open-market trades the lifetime net is −$13.5M, making them a net seller over the disclosed history. 52 SEC filings were submitted jointly with CUBIST PHARMACEUTICALS INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

52

Lifetime Open-Market Net

-$13.46M

Filer Profile

Reported Address
37 WHITETAIL WAY
LITTLETON, MA 01460
Related Filers
CUBIST PHARMACEUTICALS INC — 52 joint filings, latest 2014-10-02
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Achaogen, Inc. (AKAO) Delisted Director — — — $0 4 2018-06-07
CUBIST PHARMACEUTICALS INC (CBST.Z) Delisted SVP, Commercial Operations 18,689 — — -$6.16M 7 2014-10-02
CUBIST PHARMACEUTICALS INC (CBST) Delisted SVP, Commercial Operations 14,523 — — -$7.30M 41 2013-10-02

Recent Filings

52 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-06-07 Achaogen, Inc. (AKAO) Delisted Grant (A) — $0 EDGAR
2017-06-16 Achaogen, Inc. (AKAO) Delisted Grant (A) — $0 EDGAR
2016-06-17 Achaogen, Inc. (AKAO) Delisted Grant (A) — $0 EDGAR
2015-06-11 Achaogen, Inc. (AKAO) Delisted Grant (A) — $0 EDGAR
2014-10-02 CUBIST PHARMACEUTICALS INC (CBST.Z) Delisted Other (J) +14 $929 EDGAR
2014-08-20 CUBIST PHARMACEUTICALS INC (CBST.Z) Delisted Mixed — -$1.09M EDGAR
2014-07-02 CUBIST PHARMACEUTICALS INC (CBST.Z) Delisted Other (J) +105 $7.3K EDGAR
2014-03-06 CUBIST PHARMACEUTICALS INC (CBST.Z) Delisted Mixed — -$830.5K EDGAR
2014-02-19 CUBIST PHARMACEUTICALS INC (CBST.Z) Delisted Mixed +2,087 -$73.9K EDGAR
2014-01-15 CUBIST PHARMACEUTICALS INC (CBST.Z) Delisted Mixed — -$213.0K EDGAR
Showing 1–10 of 52
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.